Air Filter with `Catch and Kill` Technology Eliminates Airborne Viruses, Including COVID-19 Variants
By HospiMedica International staff writers Posted on 07 Jan 2022 |
The only air filter in the world proven to "catch and kill" airborne COVID-19, Anthrax spores, bacteria, allergens, and other asthma triggers was launched at the 2022 Consumer Electronics Show (CES).
Integrated Viral Protection, LLC (Houston, TX, USA) demonstrated its scientifically proven technology with the release of its new Personal Air Filtration Unit to provide additional protection with the vaccine.
IVP allows breathing with confidence by changing the way air is cleaned. This patented technology, based on science, kills airborne viruses in a single pass, including sub-micron variants causing COVID-19, anthrax spores, allergens, and other harmful respiratory triggers. IVP units use a heated foam stainless steel mesh embedded inside a HEPA filter to kill airborne pathogens instantly and removing these pathogens from the air.
The FDA EUA approved Personal Air Filtration Unit was designed to reduce person-to-person virus transmission and is ideal for schools, office spaces, mass transit, and other small indoor spaces IVP's products have been deployed in businesses, health care facilities, schools, and homes around the globe, providing an extra layer of protection to keep indoor spaces safer.
"The time for action is now to combat this virus and its many mutations," said Monzer Hourani, inventor of IVP's indoor air protection system.
Related Links:
Integrated Viral Protection, LLC
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans